1. Articles from biospace.com

  2. 1-24 of 97 1 2 3 4 »
    1. Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

      Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

      MONTREAL and CHARLOTTE, N.C., Sept. 22, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Lisa Giles and Robert Wills to its Board of Directors...

      Read Full Article
    2. Protagonist Appoints Sarah O'Dowd to Board of Directors

      Protagonist Appoints Sarah O'Dowd to Board of Directors

      Protagonist Therapeutics, Inc., Inc. (Nasdaq:PTGX) today announced the appointment of Sarah O'Dowd as an independent director to the Protagonist Board of Directors. Ms. O'Dowd brings broad experience in management and corporate governance to Protagonist, including senior level oversight in the biopharmaceutical industry. In connection with the appointment, Chaitan Khosla, Ph.D., Professor of Chemistry and Engineering at Stanford University, is stepping down from his position on the board...

      Read Full Article
    3. Greg Lucier Joins Berkeley Lights' Board of Directors

      Greg Lucier Joins Berkeley Lights' Board of Directors

      PRNewswire/ -- Today Berkeley Lights, Inc., a leader in Digital Cell Biology, announced the appointment of Gregory T. Lucier to the Berkeley Lights Board of Directors. An established thought leader in the life sciences industry, Mr. Lucier has over 25 years of experience in developing and growing innovation-driven companies into market leaders, with expertise in contemporary corporate governance..

      Read Full Article
    4. Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

      Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

      DURHAM, N.C., March 11, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, announced today that Geno Germano, President and CEO of Elucida Oncology, has been appointed to the company’s Board of Directors...

      Read Full Article
    1-24 of 97 1 2 3 4 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content